BOUL: Organic growth and positive cash flow achieved despite currency headwinds and lower sales

About this update from Boule Diagnostics Ab

Organic growth returned in Q1 2026, but reported sales fell 10% due to currency headwinds. Operating cash flow turned positive for the fourth straight quarter, and site consolidation was completed, with strong outlooks for both Diagnostics and OEM segments.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Boule Diagnostics Ab